A drug development programme to shorten and simplify treatment of tuberculosis.

Joined March 2017
38 Photos and videos
5 Jun 2025
Day 3 — the final day of the SimpliciTB & PanACEA II close-out meeting. Today we’re not just wrapping up, we’re planning forward: shaping the future of TB research, collaboration & innovation. Grateful for the journey, excited for what’s ahead. @edctp @tballiance #endTB
1
1
77
4 Jun 2025
Kicking off Day 2 of the SimpliciTB & Panacea II close out Meeting in Cape Town! Yesterday reminded us how far we’ve come — from milestones in clinical progress to growing global partnerships. Onward together in the fight against #TB. @EDCTP @TBAlliance #PanaceaII #EndTB
2
3
107
3 Jun 2025
The joint final annual meeting of #SimplicitTB and #PanaceaII kicks off in Cape Town! Looking forward to an inspiring 3 days of collaboration, science & progress in TB research. Let’s go! 🇿🇦 #TBResearch #GlobalHealth #CapeTown #EDCTP #endtb
1
5
247
15 Nov 2023
Exciting news from Uganda! Our 6the partner site is now officially ready for patient enrollment in our PanACEA II STEP2C trial!! @EDCTP @MakerereHosp #EndTB
5
198
15 Nov 2023
Looking back at another great edition of the EDCTP forum! We were very happy to see so many of our PanACEA members attending and contributing to the insightful sessions. And we were proud to see some of the amazing PanACEA work presented! @EDCTP @KCRITanzania @TBtrials_StAnd
3
221
10 Nov 2023
We are happy to announce that after the SIV our site in Malawi is now ready to start with the STEP2C study! @EDCTP @MakerereHosp @Makerere #EndTB
1
4
227
9 Nov 2023
Great presentation from our partner dr. Caryn Upton at the EDCTP forum in Paris @taskapplied @EDCTP @TBtrials_StAnd
4
9
609
PanACEA retweeted
Delighted to meet our partners at #EDCTPForum learning about the new @EDCTP programme and opportunities for collaboration #EndTB @SabiitiwWilber @Infection_StAnd @UStAResearch @StAndMedicine @TBAlliance @PanACEA_II
4
4
380
2 Mar 2023
We successfully completed our first site initiation visit for the STEP2C study at TASK in South Africa. We are so excited to start enrolling our first patient soon! @PanACEA_II @EDCTP
2
3
19
2,130
21 Feb 2023
Today Norbert Heinrich presented the PanACEA SUDOCU study results at @CROI_Official in Seattle: sutezolid on top of a background regimen (bedaquiline, delamanid, moxifloxacin) was well tolerated when given over 12 weeks and improved the treatment efficacy modestly. TNX to @EDCTP
2
23
1,034
21 Sep 2022
After two years of COVID we are finally reunited with our PanACEA family in #Malawi. With special thanks to our host @KUHeS_mw. @EDCTP @TBtrials_StAnd
1
5
24
PanACEA retweeted
A busy first day at our Annual Scientific Meeting is followed by a fantastic dinner at Ekhaya Lodge #Mangochi SimpliciTB @PanACEA_II @EDCTP @TBAlliance @StAndMedicine @Infection_StAnd
2
11
PanACEA retweeted
19 Sep 2022
Our Centre Director @NNtinginya presenting on the clinical utility of the Molecular Bacterial Load Assay (MBLA) in monitoring TB therapy through the @EDCTP funded SimpliciTB-PanACEA network at Kamuzu University of Health Sciences, Malawi @KUHeS_mw @PanACEA_II
1
4
27
PanACEA retweeted
Looking forward to welcoming our SimpliciTB delegates arriving @MakokolaRetreat #Malawi ready for our Annual Scientific Meeting with @PanACEA_II @EDCTP @TBAlliance @StAndMedicine @Infection_StAnd #Takulandilani
3
9
16 Sep 2022
Status update: DECODE recruitment finalized! This is the second dose finding study PanACEA completed in 2022. We continue to work together with LegoChemBio to get those long anticipated delpazolid exposure-response results. clinicaltrials.gov/ct2/show/…

1
5
24 Feb 2022
clinicaltrials.gov/ct2/show/… “STATUS update: SUDOCU completed recruitment! Now all efforts towards wrapping up participant follow-up and data collection. Hopefully soon more sutezolid exposure-response results...”

1
6